Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Flares and definition of worsening in inflammatory myopathies: a narrative review of the literature.

Created on 19 Sep 2026

Authors

Maria Rosa Pellico, Mert Öztaş, Latika Gupta

Published in

Rheumatology (Oxford, England). Sep 18, 2026. Epub Sep 18, 2026.

Abstract

Idiopathic inflammatory myopathies (IIM) follow a chronic, polycyclic course in a substantial proportion of patients. Unlike remission, which has recently been standardised, the definition of flare (or worsening) remains highly heterogeneous, creating a divide between clinical trials and real-world practice. Validated core set definitions of worsening exist for trials but were derived by consensus on paper patient profiles and are criticised for inadequate content validity; observational studies instead rely on simplified markers such as enzyme elevation or therapeutic escalation. This review summarises existing definitions, contrasting the IMACS and PRINTO statistical criteria with the variable definitions used in longitudinal cohorts. We examine reported flare rates and predictors, the discordance between global and organ-specific (skin, muscle, lung) worsening, and the lessons offered by flare definitions in other rheumatic and inflammatory diseases. We then propose a multi-domain, treatment-anchored framework intended to bridge statistical rigour and clinical utility.

PMID:
42760264
Bibliographic data and abstract were imported from PubMed on 19 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 15
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement